Advertisement

Topics

Androgen-Deprivation Therapy and Cardiovascular Risk: A Nationwide Population-based Cohort Study

2016-09-11 18:01:15 | BioPortfolio

Published on BioPortfolio: 2016-09-11T18:01:15-0400

Clinical Trials [3490 Associated Clinical Trials listed on BioPortfolio]

Correlation of Imaging Findings With Clinical Findings and Patient Outcomes in Prostate Cancer

MRI is being increasingly relied upon for detection, staging and management of prostate cancer. In this study patients with risk of prostate cancer will be recommended to have a pelvic MRI...

Assess Gamma H2AX Positivity in Circulating Prostate Cancer Cells Before and After Radium 223

This is a prospective biomarker study on prostate cancer patients receiving Radium 223 as standard of care. Participants will take part in this research study because they have chosen Rad...

Use of β-hydroxy-β-methylbutyrate to Counteract Muscle Loss in Men With Prostate Cancer on Androgen Ablation

This is a study of HMB plus amino acids in older men with prostate cancer starting androgen deprivation therapy (ADT). The investigators hypothesize that the use of this nutritional suppl...

Repurposing Metformin as Anticancer Drug: in Advanced Prostate Cancer

This study evaluate the addition of metformin to standard of care in locally advanced and metastatic prostate cancer, half the patient will receive metformin in combination with standard t...

Staying Strong and Healthy During Androgen Deprivation Therapy (ADT) for Men

The purpose of this study is to learn if lifestyle changes and counseling along with standard medical care, compared to standard medical care alone, can prevent heart problems and diabetes...

PubMed Articles [27033 Associated PubMed Articles listed on BioPortfolio]

Thinking about one's own death after prostate-cancer diagnosis.

Prostate-cancer diagnosis increases the risk for psychiatric morbidity and suicide. Thoughts about one's own death could indicate need for psychiatric care among men with localized prostate cancer. We...

Increased resource use in men with metastatic prostate cancer does not result in improved survival or quality of care at the end of life.

Cancer care and end-of-life (EOL) care contribute substantially to health care expenditures. Outside of clinical trials, to our knowledge there exists no standardized protocol to monitor disease progr...

Improving risk stratification among veterans diagnosed with prostate cancer: impact of the 17-gene prostate score assay.

Active surveillance (AS) has been widely implemented within Veterans Affairs' medical centers (VAMCs) as a standard of care for low-risk prostate cancer (PCa). Patient characteristics such as age, rac...

Early effect of Medicare Shared Savings Program accountable care organization participation on prostate cancer care.

Accountable care organizations (ACOs) can improve prostate cancer care by decreasing treatment variations (ie, avoidance of treatment in low-value settings). Herein, the authors performed a study to u...

Next-generation prostate cancer risk calculator for primary care physicians.

Current prostate cancer risk calculators are limited in impact because only a probability of having prostate cancer is provided. We developed the next generation of prostate cancer risk calculator tha...

Medical and Biotech [MESH] Definitions

A glycoprotein that is a kallikrein-like serine proteinase and an esterase, produced by epithelial cells of both normal and malignant prostate tissue. It is an important marker for the diagnosis of prostate cancer.

A synthetic retinoid that is used orally as a chemopreventive against prostate cancer and in women at risk of developing contralateral breast cancer. It is also effective as an antineoplastic agent.

Institutions specializing in the care of cancer patients.

Tissue ablation of the PROSTATE performed by ultrasound from a transducer placed in the RECTUM. The procedure is used to treat prostate cancer (PROSTATIC NEOPLASMS) and benign prostatic hypertrophy (PROSTATIC HYPERPLASIA).

Proteins secreted by the prostate gland. The major secretory proteins from the human prostate gland include PROSTATE-SPECIFIC ANTIGEN, prostate-specific acid phosphatase, prostate-specific membrane antigen, and prostate-specific protein-94.

More From BioPortfolio on "Androgen-Deprivation Therapy and Cardiovascular Risk: A Nationwide Population-based Cohort Study"

Advertisement
Quick Search
Advertisement
Advertisement

 

Searches Linking to this Trial